BDBM272082 (S)-1-Cyclopentyl-5-(3-fluoro-2-methylphenyl)-N- hydroxy-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-5- carboxamide::US10065948, 18::US10457675, Example 18

SMILES: Cc1c(F)cccc1[C@@]1(Cc2cnn(C3CCCC3)c2C1)C(=O)NO

InChI Key: InChIKey=VCMRQVYOIDBWLI-IBGZPJMESA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 272082   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Histone deacetylase 9 (Homo sapiens (Human))	BDBM272082 ((S)-1-Cyclopentyl-5-(3-fluoro-2-methylphenyl)-N- h...) Show SMILES Cc1c(F)cccc1[C@@]1(Cc2cnn(C3CCCC3)c2C1)C(=O)NO |r| Show InChI InChI=1S/C19H22FN3O2/c1-12-15(7-4-8-16(12)20)19(18(24)22-25)9-13-11-21-23(17(13)10-19)14-5-2-3-6-14/h4,7-8,11,14,25H,2-3,5-6,9-10H2,1H3,(H,22,24)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a	n/a
CHDI Foundation, Inc. US Patent					Assay Description The potency of the compounds is quantified by measuring the Histone Deacetylase 9 (HDAC9) enzymatic activity using the fluorogenic substrate, Boc-Lys...				US Patent US10457675 (2019) BindingDB Entry DOI: 10.7270/Q22J6F7J
					More data for this Ligand-Target Pair
Histone deacetylase 9 (Homo sapiens (Human))	BDBM272082 ((S)-1-Cyclopentyl-5-(3-fluoro-2-methylphenyl)-N- h...) Show SMILES Cc1c(F)cccc1[C@@]1(Cc2cnn(C3CCCC3)c2C1)C(=O)NO |r| Show InChI InChI=1S/C19H22FN3O2/c1-12-15(7-4-8-16(12)20)19(18(24)22-25)9-13-11-21-23(17(13)10-19)14-5-2-3-6-14/h4,7-8,11,14,25H,2-3,5-6,9-10H2,1H3,(H,22,24)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a	n/a
CHDI Foundation, Inc. US Patent					Assay Description The potency of the compounds is quantified by measuring the Histone Deacetylase 9 (HDAC9) enzymatic activity using the fluorogenic substrate, Boc-Lys...				US Patent US10065948 (2018) BindingDB Entry DOI: 10.7270/Q2154K23
					More data for this Ligand-Target Pair